BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28867760)

  • 1. In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography.
    Doishita S; Shimono T; Yoneda T; Yamada E; Tsukamoto T; Takemori D; Kimura D; Tatekawa H; Sakamoto S; Miki Y
    Magn Reson Med Sci; 2018 Jan; 17(1):58-66. PubMed ID: 28867760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
    Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
    J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.
    Dyke JP; Sanelli PC; Voss HU; Serventi JV; Stieg PE; Schwartz TH; Ballon D; Shungu DC; Pannullo SC
    J Neurooncol; 2007 Mar; 82(1):103-10. PubMed ID: 17031552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma.
    Giese A; Kucinski T; Knopp U; Goldbrunner R; Hamel W; Mehdorn HM; Tonn JC; Hilt D; Westphal M
    J Neurooncol; 2004 Feb; 66(3):351-60. PubMed ID: 15015668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
    Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
    Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis.
    Mu F; Lucas JT; Watts JM; Johnson AJ; Daniel Bourland J; Laxton AW; Chan MD; Tatter SB
    J Clin Neurosci; 2015 Mar; 22(3):561-5. PubMed ID: 25560387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
    Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
    J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-181d Expression Significantly Affects Treatment Responses to Carmustine Wafer Implantation.
    Sippl C; Ketter R; Bohr L; Kim YJ; List M; Oertel J; Urbschat S
    Neurosurgery; 2019 Jul; 85(1):147-155. PubMed ID: 29846701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
    Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
    J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma.
    Masuda Y; Ishikawa E; Yamamoto T; Matsuda M; Akutsu H; Kohzuki H; Nakai K; Okamoto E; Takano S; Masumoto T; Matsumura A
    Magn Reson Med Sci; 2016 Jul; 15(3):299-307. PubMed ID: 26726015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.
    Pallud J; Audureau E; Noel G; Corns R; Lechapt-Zalcman E; Duntze J; Pavlov V; Guyotat J; Hieu PD; Le Reste PJ; Faillot T; Litre CF; Desse N; Petit A; Emery E; Voirin J; Peltier J; Caire F; Vignes JR; Barat JL; Langlois O; Dezamis E; Parraga E; Zanello M; Nader E; Lefranc M; Bauchet L; Devaux B; Menei P; Metellus P;
    Neuro Oncol; 2015 Dec; 17(12):1609-19. PubMed ID: 26185110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma.
    Matsumura H; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Takano S; Matsumura A
    Neurol Med Chir (Tokyo); 2018 Jun; 58(6):270-276. PubMed ID: 29780071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review.
    Zhang YD; Dai RY; Chen Z; Zhang YH; He XZ; Zhou J
    Turk Neurosurg; 2014; 24(5):639-45. PubMed ID: 25269031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
    Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.